These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 9590567

  • 1. Allosteric interactions at muscarinic cholinoceptors.
    Christopoulos A, Lanzafame A, Mitchelson F.
    Clin Exp Pharmacol Physiol; 1998; 25(3-4):185-94. PubMed ID: 9590567
    [Abstract] [Full Text] [Related]

  • 2. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.
    Franken C, Tränkle C, Mohr K.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):107-12. PubMed ID: 10685864
    [Abstract] [Full Text] [Related]

  • 3. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
    Lanzafame A, Christopoulos A, Mitchelson F.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
    Schröter A, Tränkle C, Mohr K.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
    [Abstract] [Full Text] [Related]

  • 7. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
    Krejcí A, Tucek S.
    Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
    [Abstract] [Full Text] [Related]

  • 8. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
    Tränkle C, Weyand O, Voigtländer U, Mynett A, Lazareno S, Birdsall NJ, Mohr K.
    Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
    [Abstract] [Full Text] [Related]

  • 9. Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.
    Tränkle C, Mies-Klomfass E, Cid MH, Holzgrabe U, Mohr K.
    Mol Pharmacol; 1998 Jul; 54(1):139-45. PubMed ID: 9658199
    [Abstract] [Full Text] [Related]

  • 10. Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors.
    Pfaffendorf M, Batink HD, Tränkle C, Mohr K, van Zwieten PA.
    J Auton Pharmacol; 2000 Feb; 20(1):55-62. PubMed ID: 11048962
    [Abstract] [Full Text] [Related]

  • 11. Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity.
    Prilla S, Schrobang J, Ellis J, Höltje HD, Mohr K.
    Mol Pharmacol; 2006 Jul; 70(1):181-93. PubMed ID: 16641315
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the subtype selectivity of the allosteric modulator heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl) ammonium bromide (C7/3-phth) at cloned muscarinic acetylcholine receptors.
    Christopoulos A, Sorman JL, Mitchelson F, El-Fakahany EE.
    Biochem Pharmacol; 1999 Jan 15; 57(2):171-9. PubMed ID: 9890565
    [Abstract] [Full Text] [Related]

  • 13. Allosteric modulators and selective agonists of muscarinic receptors.
    Holzgrabe U, De Amici M, Mohr K.
    J Mol Neurosci; 2006 Jan 15; 30(1-2):165-8. PubMed ID: 17192667
    [Abstract] [Full Text] [Related]

  • 14. Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors.
    Lanzafame A, Christopoulos A, Mitchelson F.
    Eur J Pharmacol; 1996 Nov 28; 316(1):27-32. PubMed ID: 8982646
    [Abstract] [Full Text] [Related]

  • 15. Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at M1 and M2 muscarine receptors.
    Christopoulos A, Mitchelson F.
    Mol Pharmacol; 1994 Jul 28; 46(1):105-14. PubMed ID: 8058045
    [Abstract] [Full Text] [Related]

  • 16. The impact of orthosteric radioligand depletion on the quantification of allosteric modulator interactions.
    Avlani VA, McLoughlin DJ, Sexton PM, Christopoulos A.
    J Pharmacol Exp Ther; 2008 Jun 28; 325(3):927-34. PubMed ID: 18322151
    [Abstract] [Full Text] [Related]

  • 17. Interaction studies of multiple binding sites on m4 muscarinic acetylcholine receptors.
    Lanzafame AA, Sexton PM, Christopoulos A.
    Mol Pharmacol; 2006 Aug 28; 70(2):736-46. PubMed ID: 16709648
    [Abstract] [Full Text] [Related]

  • 18. Application of an allosteric ternary complex model to the technique of pharmacological resultant analysis.
    Christopoulos A, Mitchelson F.
    J Pharm Pharmacol; 1997 Aug 28; 49(8):781-6. PubMed ID: 9379356
    [Abstract] [Full Text] [Related]

  • 19. The allosteric site regulates the voltage sensitivity of muscarinic receptors.
    Hoppe A, Marti-Solano M, Drabek M, Bünemann M, Kolb P, Rinne A.
    Cell Signal; 2018 Jan 28; 42():114-126. PubMed ID: 29056499
    [Abstract] [Full Text] [Related]

  • 20. The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M2 receptors in guinea pig atria.
    Lanzafame A, Christopoulos A, Mitchelson F.
    Eur J Pharmacol; 2001 Mar 30; 416(3):235-44. PubMed ID: 11290374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.